Open AccessA phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy
Author(s) -
Harumitsu Kumagai,
Hitoshi Kusaba,
T. Yamanaka,
Kenta Nio,
Kyoko Inadomi,
Kotoe Takayoshi,
Mamoru Ito,
Shingo Tamura,
Akitaka Makiyama,
Chinatsu Makiyama,
Gen Hirano,
Yoshihiro Shibata,
Tsuyoshi Shirakawa,
Kenji Mitsudo,
Hiroshi Ariyama,
Taito Esaki,
Koichi Akashi,
Eishi Baba
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000011042
Subject(s) - medicine , antiemetic , vomiting , dexamethasone , granisetron , chemotherapy , nausea , gastroenterology , phases of clinical research , clinical endpoint , anesthesia , clinical trial